matrihealth meets BACB


the Business Angels Club Berlin Brandenburg e.V. invited us to their Pitch Day on 04.07. at the Bürgschaftsbank Berlin-Brandenburg to present our start-up together with 7 other start-ups in front of the members and guests of the BACB! It was a great evening with good conversations in a pleasant atmosphere. We are also very proud to have received the award for the best pitch!

We are INVEST-eligible!


matrihealth is eligible for funding under the INVEST funding measure of the German Federal Ministry for Economic Affairs and Climate Action! The program subsidizes venture capital invested by private investors in young and innovative companies like matrihealth. Request more information about our company at!

We are in!


We have another reason to be happy! We have applied for the participation at the Investor Days Thuringia 2023 in Erfurt, and could convince the selection committee! We are now allowed to present our ideas and visions to potential investors on 14.06. and 15.06. together with 39 other start-ups! We are very much looking forward to it and an exciting exchange!

matrihealth on Tour!


We are starting to like it in Munich! We had the opportunity to present our startup at the 3rd Occident Pitch Event of the Occident Group! It was an exciting evening with great start-ups and many conversations. Many thanks to the Occident Group and univations GmbH from Halle for letting us participate!

matrihealth is now Member of the Life Science Cluster Sachsen Anhalt


We are now an official member of the Life-Science-Cluster Saxony-Anhalt. The Life-Science-Cluster sees itself as a network and interest group for the strengthening and networking of companies and research institutions in the fields of biotechnology, pharmacy as well as medicine and health in Saxony-Anhalt and Central Germany.




matrihealth on Tour!


We are once again on the road in terms of investor search and are happy to be part of the Start Up Investor Days "4 Investors" in Munich today! The event is hosted by the four major non-university research institutions of the Max Planck Society, the Helmholtz Association, the Leibnitz Association and the Fraunhofer Society and only a limited number of spin-offs from these research institutions are allowed to present themselves to potential investors. We are looking forward to being there!


ELMA is here!


We are very excited to introduce our first commercial product today! With our ELMA, methacylated elastin will soon be available for 3D printing for the first time! As an essential component of the extracellular matrix of all elastic tissues, our ELMA enables the production of artificial tissues by bioprinting!

matrihealth on tour! 


We are pleased to be present for the first time this year at the annual ESAO Symposium on Artificial Organs and Tissue Engineering. The symposium will take place in Wittenberg, Germany, from Feb. 15 to Feb. 18, 23. We are especially looking forward to present our ELMA, methacrylated elastin for biorprinting, for the first time. We are looking forward to exciting discussions and interesting insights into current research.


More information: 

      © ESAO

matriheal goes matrihealth 


On 04.10.2022 it was finally time, after almost 2 years of preparation, the notary appointment took place in Halle (Saale) and we could finally found the matrihealth GmbH! Many thanks to all who accompanied and supported us on the exciting way! We are looking forward to the coming time and to take the next steps together with you!

We are in! 


On November 23, 2022, the Fraunhofer Investment Forum 2022 will take place digitally and on-site in Munich. Together with other exciting spin-offs of the Fraunhofer Gesellschaft, we will have the opportunity to pitch to interested investors and hold exciting discussions. We are looking forward to it! 

Become a part of our story!


We are looking for investors and supporters with experience in the MedTech industry:


// Sales cooperation  
// Strategic partnerships
// Partners for approval and certification


Contact us!

      © 2022

      © Fraunhofer IMWS / Michael Deutsch

Wir benötigen Ihre Zustimmung zum Laden der Übersetzungen

Wir nutzen einen Drittanbieter-Service, um den Inhalt der Website zu übersetzen, der möglicherweise Daten über Ihre Aktivitäten sammelt. Bitte prüfen Sie die Details und akzeptieren Sie den Dienst, um die Übersetzungen zu sehen.